Spun out of the nonprofit Caring Cross, Vector BioMed develops and manufactures lentiviral vectors for gene and cell therapy programs. Its LENTIVERSE™ platform combines custom vector engineering with ready-to-deploy solutions for CAR-T manufacturing, using a platform-based approach intended to shorten the path from concept to clinic. The Gaithersburg public benefit corporation pairs decades of lentiviral experience with a focus on transparent economics and expanding access to advanced therapies worldwide.